Cov-MS: A Community-Based Template Assay for Mass-Spectrometry-Based Protein Detection in SARS-CoV-2 Patients-Reference-Cited by-同舟云学术

Cov-MS: A Community-Based Template Assay for Mass-Spectrometry-Based Protein Detection in SARS-CoV-2 Patients

Published:2021-05-03 Issue:6 Volume:1 Page:750-765
ISSN:2691-3704
Container-title:JACS Au
language:en
Short-container-title:JACS Au

Author:

Van Puyvelde Bart¹,Van Uytfanghe Katleen²,Tytgat Olivier¹³,Van Oudenhove Laurence⁴,Gabriels Ralf⁵⁶^ORCID,Bouwmeester Robbin⁵⁶^ORCID,Daled Simon¹,Van Den Bossche Tim⁵⁶^ORCID,Ramasamy Pathmanaban⁵⁶⁷^ORCID,Verhelst Sigrid¹,De Clerck Laura¹,Corveleyn Laura¹,Willems Sander¹,Debunne Nathan⁸^ORCID,Wynendaele Evelien⁸,De Spiegeleer Bart⁸^ORCID,Judak Peter⁹,Roels Kris⁹,De Wilde Laurie⁹^ORCID,Van Eenoo Peter⁹,Reyns Tim¹⁰,Cherlet Marc¹¹,Dumont Emmie¹²,Debyser Griet¹²,t’Kindt Ruben¹²,Sandra Koen¹²,Gupta Surya⁵⁶^ORCID,Drouin Nicolas¹³,Harms Amy¹³,Hankemeier Thomas¹³^ORCID,Jones Donald J. L.¹⁴^ORCID,Gupta Pankaj¹⁵,Lane Dan¹⁵,Lane Catherine S.¹⁶,El Ouadi Said¹⁶,Vincendet Jean-Baptiste¹⁶,Morrice Nick¹⁶,Oehrle Stuart¹⁷,Tanna Nikunj¹⁷^ORCID,Silvester Steve¹⁸,Hannam Sally¹⁸,Sigloch Florian C.¹⁹^ORCID,Bhangu-Uhlmann Andrea¹⁹,Claereboudt Jan⁴,Anderson N. Leigh²⁰,Razavi Morteza²⁰,Degroeve Sven⁵⁶,Cuypers Lize²¹,Stove Christophe²^ORCID,Lagrou Katrien²¹,Martens Geert A.²²,Deforce Dieter¹,Martens Lennart⁵⁶^ORCID,Vissers Johannes P. C.¹⁷^ORCID,Dhaenens Maarten¹^ORCID

Affiliation:

1. ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Ghent, Belgium

2. Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium

3. Department of Life Science Technologies, Imec, 3000 Leuven, Belgium

4. Waters Corporation, 2600 Antwerp, Belgium

5. VIB-UGent Center for Medical Biotechnology, VIB, 9000 Ghent, Belgium

6. Department of Biomolecular Medicine, Ghent University, 9000 Ghent Belgium

7. Interuniversity Institute of Bioinformatics in Brussels, ULB/VUB, 1050 Brussels, Belgium

8. Drug Quality and Registration Group, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium

9. Doping Control Laboratory, Department of Diagnostic Sciences, Ghent University, 9000 Ghent, Belgium

10. Department of Clinical Chemistry, Ghent University Hospital, 9000 Ghent, Belgium

11. Department of Pharmacology, Toxicology, and Biochemistry, Faculty of Veterinary Medicine, Ghent University 9000 Ghent, Belgium

12. Research Institute for Chromatography (RIC), 8500 Kortrijk, Belgium

13. Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, 2311 G Leiden, The Netherlands

14. Leicester Cancer Research Centre, RKCSB, University of Leicester, U.K., and John and Lucille van Geest Biomarker Facility, Cardiovascular Research Centre, Glenfield Hospital, Leicester LE1 7RH, United Kingdom

15. The Department of Chemical Pathology and Metabolic Diseases, Level 4, Sandringham Building, Leicester Royal Infirmary, Leicester LE1 7RH, United Kingdom

16. AB Sciex, Alderley Park, Macclesfield SK10 4TG, United Kingdom

17. Waters Corporation, Milford, Massachusetts 01757, United States

18. Alderley Analytical, Alderley Park, Macclesfield SK10 4TG, United Kingdom

19. Polyquant GmbH, 93077 Bad Abbach, Germany

20. SISCAPA Assay Technologies, Inc., Washington, D.C. 20009, United States

21. Clinical Department of Laboratory Medicine, UZ Leuven, KU Leuven, 3000 Leuven, Belgium

22. AZ Delta Medical Laboratories, AZ Delta General Hospital, 8800 Roeselare, Belgium

Funder

Fonds Wetenschappelijk Onderzoek

Horizon 2020 Framework Programme

Bijzonder Onderzoeksfonds

Publisher

American Chemical Society (ACS)

Subject

General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jacsau.1c00048

Reference51 articles.

1. OECD. Testing for COVID-19: A way to lift confinement restrictions 2020, May, 1–21; https://www.oecd.org/coronavirus/policy-responses/testing-for-covid-19-a-way-to-lift-confinement-restrictions-89756248/ (accessed March 29, 2021).

2. False-positive COVID-19 results: hidden problems and costs

3. FDA. SARS-CoV-2 Reference Panel Comparative Data; https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-reference-panel-comparative-data.

4. ASM. ASM Expresses Concern about Coronavirus Test Reagent Shortages, 2020; https://asm.org/Articles/Policy/2020/March/ASM-Expresses-Concern-about-Test-Reagent-Shortages#:text=ASM%20Expresses%20Concern%20About%20Coronavirus%20Test%20Reagent%20Shortages,March%2010%2C%202020&text=Clinical%20microbiologists%20and%20clinical%20labs,the%20response%20to%20COVID%2D19.&text=We%20applaud%20the%20CDC%20for,specimen%20swab%20instead%20of%20two (accessed March 29, 2021).

5. CEBM. Are you infectious if you have a positive PCR test result for COVID-19? 2020; https://www.cebm.net/covid-19/infectious-positive-pcr-test-result-covid-19/ (accessed March 29, 2021).

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wastewater-based proteomics: A proof-of-concept for advancing early warning system for infectious diseases and immune response monitoring;Journal of Hazardous Materials Letters;2024-11

2. vPro-MS enables identification of human-pathogenic viruses from patient samples by untargeted proteomics;2024-08-21

3. A Targeted LC-MRM3 Proteomic Approach for the Diagnosis of SARS-CoV-2 Infection in Nasopharyngeal Swabs;Molecular & Cellular Proteomics;2024-07

4. Acoustic ejection mass spectrometry empowers ultra-fast protein biomarker quantification;Nature Communications;2024-06-15

5. Enhancing the understanding of SARS-CoV-2 protein with structure and detection methods: An integrative review;International Journal of Biological Macromolecules;2024-06